1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    


































































































































































































    The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Review ArticleReview Articles

  
      
Open Access

  
      
The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis
  
    	
F. Agosta, A. Chiò, M. Cosottini, N. De Stefano, A. Falini, M. Mascalchi, M.A. Rocca, V. Silani, G. Tedeschi and M. Filippi

  
    	
American Journal of Neuroradiology November 2010,  31 (10) 1769-1777; DOI: https://doi.org/10.3174/ajnr.A2043 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Ravits  JM, 
    2. La Spada  AR
    . ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009;73:805–11
    Abstract/FREE Full Text
  2. 2.↵


    1. Dion  PA, 
    2. Daoud  H, 
    3. Rouleau  GA
    . Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 2009;10:769–82
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Neumann  M, 
    2. Sampathu  DM, 
    3. Kwong  LK, 
    4. et al
    . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130–33
    Abstract/FREE Full Text
  4. 4.↵


    1. Leigh  PN, 
    2. Abrahams  S, 
    3. Al-Chalabi  A, 
    4. et al
    . The management of motor neurone disease. J Neurol Neurosurg Psychiatry 2003;74(suppl 4):iv32–iv47
    FREE Full Text
  5. 5.↵


    1. Andersen  PM, 
    2. Borasio  GD, 
    3. Dengler  R, 
    4. et al
    . EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12:921–38
    CrossRefPubMedWeb of Science
  6. 6.↵


    1. Chio  A, 
    2. Cucatto  A, 
    3. Calvo  A, 
    4. et al
    . Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. J Neurol 1999;246:175–80
    CrossRefPubMed
  7. 7.↵


    1. Millul  A, 
    2. Beghi  E, 
    3. Logroscino  G, 
    4. et al
    . Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005;25:114–19
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Zoccolella  S, 
    2. Beghi  E, 
    3. Palagano  G, 
    4. et al
    . Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci 2006;250:45–49
    CrossRefPubMed
  9. 9.↵


    1. Brooks  BR
    . Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life. Ann Neurol 2009;65(suppl 1):S17–23
    CrossRefPubMed
  10. 10.↵


    1. Brooks  BR, 
    2. Miller  RG, 
    3. Swash  M, 
    4. et al
    . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–99
    CrossRefPubMedWeb of Science
  11. 11.↵


    1. Turner  MR, 
    2. Kiernan  MC, 
    3. Leigh  PN, 
    4. et al
    . Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009;8:94–109
    CrossRefPubMedWeb of Science
  12. 12.↵


    1. Dickson  DW
    1. Kato  S, 
    2. Shaw  P, 
    3. Wood-Allum  C, 
    4. et al
    . Amyotrophic lateral sclerosis. In: 

Dickson  DW, ed. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel, Switzerland: ISN Neuropath Press; 2003:350–71
  13. 13.↵


    1. Lule  D, 
    2. Ludolph  AC, 
    3. Kassubek  JM
    . I-based functional neuroimaging in ALS: an update. Amyotroph Lateral Scler 2009;10:258–68
    CrossRefPubMed
  14. 14.↵


    1. Goodin  DS, 
    2. Rowley  HA, 
    3. Olney  RK
    . Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol 1988;23:418–20
    CrossRefPubMedWeb of Science
  15. 15.↵


    1. Abe  K, 
    2. Fujimura  H, 
    3. Kobayashi  Y, 
    4. et al
    . Degeneration of the pyramidal tracts in patients with amyotrophic lateral sclerosis: a premortem and postmortem magnetic resonance imaging study. J Neuroimaging 1997;7:208–12
    PubMedWeb of Science
  16. 16.↵


    1. Cheung  G, 
    2. Gawel  MJ, 
    3. Cooper  PW, 
    4. et al
    . Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995;194:263–70
    PubMedWeb of Science
  17. 17.↵


    1. Hecht  MJ, 
    2. Fellner  F, 
    3. Fellner  C, 
    4. et al
    . MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images. J Neurol Sci 2001;186:37–44
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. Hecht  MJ, 
    2. Fellner  F, 
    3. Fellner  C, 
    4. et al
    . Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images. J Neurol Sci 2002;199:59–65
    CrossRefPubMed
  19. 19.↵


    1. Ishikawa  K, 
    2. Nagura  H, 
    3. Yokota  T, 
    4. et al
    . Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis. Ann Neurol 1993;33:218–22
    CrossRefPubMed
  20. 20.↵


    1. Mirowitz  S, 
    2. Sartor  K, 
    3. Gado  M, 
    4. et al
    . Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings. Radiology 1989;172:535–39
    PubMed
  21. 21.↵


    1. Thorpe  JW, 
    2. Moseley  IF, 
    3. Hawkes  CH, 
    4. et al
    . Brain and spinal cord MRI in motor neuron disease. J Neurol Neurosurg Psychiatry 1996;61:314–17
    Abstract/FREE Full Text
  22. 22.↵


    1. Waragai  M
    . MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology 1997;39:847–51
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. Basak  M, 
    2. Erturk  M, 
    3. Oflazoglu  B, 
    4. et al
    . Magnetic resonance imaging in amyotrophic lateral sclerosis. Acta Neurol Scand 2002;105:395–99
    CrossRefPubMed
  24. 24.↵


    1. Charil  A, 
    2. Corbo  M, 
    3. Filippi  M, 
    4. et al
    . Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study. Amyotroph Lateral Scler 2009;10:269–79
    CrossRefPubMed
  25. 25.↵


    1. Satoh  JI, 
    2. Tokumoto  H, 
    3. Kurohara  K, 
    4. et al
    . Adult-onset Krabbe disease with homozygous T1853C mutation in the galactocerebrosidase gene: unusual MRI findings of corticospinal tract demyelination. Neurology 1997;49:1392–99
    Abstract/FREE Full Text
  26. 26.↵


    1. Kassubek  J, 
    2. Bretschneider  V, 
    3. Sperfeld  AD
    . Corticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth Disease. J Clin Neurosci 2005;12:588–89
    CrossRefPubMed
  27. 27.↵


    1. Teriitehau  C, 
    2. Adamsbaum  C, 
    3. Merzoug  V, 
    4. et al
    . Subtle brain abnormalities in adrenomyeloneuropathy [in French]. J Radiol 2007;88(7–8 pt 1):957–61
    CrossRefPubMed
  28. 28.↵


    1. Oba  H, 
    2. Araki  T, 
    3. Ohtomo  K, 
    4. et al
    . Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993;189:843–46
    PubMedWeb of Science
  29. 29.↵


    1. Matsusue  E, 
    2. Sugihara  S, 
    3. Fujii  S, 
    4. et al
    . Cerebral cortical and white matter lesions in amyotrophic lateral sclerosis with dementia: correlation with MR and pathologic examinations. AJNR Am J Neuroradiol 2007;28:1505–10
    Abstract/FREE Full Text
  30. 30.↵


    1. Mori  H, 
    2. Yagishita  A, 
    3. Takeda  T, 
    4. et al
    . Symmetric temporal abnormalities on MR imaging in amyotrophic lateral sclerosis with dementia. AJNR Am J Neuroradiol 2007;28:1511–16
    Abstract/FREE Full Text
  31. 31.↵


    1. Kassubek  J, 
    2. Unrath  A, 
    3. Huppertz  HJ, 
    4. et al
    . Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:213–20
    CrossRefPubMedWeb of Science
  32. 32.↵


    1. Mezzapesa  DM, 
    2. Ceccarelli  A, 
    3. Dicuonzo  F, 
    4. et al
    . Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2007;28:255–59
    Abstract/FREE Full Text
  33. 33.↵


    1. Tartaglia  MC, 
    2. Laluz  V, 
    3. Rowe  A, 
    4. et al
    . Brain atrophy in primary lateral sclerosis. Neurology 2009;72:1236–41
    Abstract/FREE Full Text
  34. 34.↵


    1. Terao  S, 
    2. Sobue  G, 
    3. Yasuda  T, 
    4. et al
    . Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis. J Neurol Sci 1995;133:66–72
    CrossRefPubMed
  35. 35.↵


    1. Mackenzie  IR, 
    2. Feldman  HH
    . Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J Neuropathol Exp Neurol 2005;64:730–39
    PubMedWeb of Science
  36. 36.↵


    1. Agosta  F, 
    2. Pagani  E, 
    3. Rocca  MA, 
    4. et al
    . Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp 2007;28:1430–38
    CrossRefPubMedWeb of Science
  37. 37.↵


    1. Grosskreutz  J, 
    2. Kaufmann  J, 
    3. Fradrich  J, 
    4. et al
    . Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 2006;6:17
    CrossRefPubMed
  38. 38.↵


    1. Chang  JL, 
    2. Lomen-Hoerth  C, 
    3. Murphy  J, 
    4. et al
    . A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 2005;65:75–80
    Abstract/FREE Full Text
  39. 39.↵


    1. Kato  S, 
    2. Hayashi  H, 
    3. Yagishita  A
    . Involvement of the frontotemporal lobe and limbic system in amyotrophic lateral sclerosis: as assessed by serial computed tomography and magnetic resonance imaging. J Neurol Sci 1993;116:52–58
    PubMedWeb of Science
  40. 40.↵


    1. Grossman  M, 
    2. Anderson  C, 
    3. Khan  A, 
    4. et al
    . Impaired action knowledge in amyotrophic lateral sclerosis. Neurology 2008;71:1396–401
    Abstract/FREE Full Text
  41. 41.↵


    1. Thivard  L, 
    2. Pradat  PF, 
    3. Lehericy  S, 
    4. et al
    . Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J Neurol Neurosurg Psychiatry 2007;78:889–92
    Abstract/FREE Full Text
  42. 42.↵


    1. Roccatagliata  L, 
    2. Bonzano  L, 
    3. Mancardi  G, 
    4. et al
    . Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:47–52
    CrossRefPubMedWeb of Science
  43. 43.↵


    1. Kiernan  JA, 
    2. Hudson  AJ
    . Frontal lobe atrophy in motor neuron diseases. Brain 1994;117(pt 4):747–57
    Abstract/FREE Full Text
  44. 44.↵


    1. Ellis  CM, 
    2. Suckling  J, 
    3. Amaro  E  Jr., 
    4. et al
    . Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology 2001;57:1571–78
    Abstract/FREE Full Text
  45. 45.↵


    1. Abrahams  S, 
    2. Goldstein  LH, 
    3. Suckling  J, 
    4. et al
    . Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005;252:321–31
    CrossRefPubMedWeb of Science
  46. 46.↵


    1. Valsasina  P, 
    2. Agosta  F, 
    3. Benedetti  B, 
    4. et al
    . Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;78:480–84
    Abstract/FREE Full Text
  47. 47.↵


    1. Agosta  F, 
    2. Rocca  MA, 
    3. Valsasina  P, 
    4. et al
    . A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2009;80:53–55
    Abstract/FREE Full Text
  48. 48.↵


    1. Gredal  O, 
    2. Rosenbaum  S, 
    3. Topp  S, 
    4. et al
    . Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997;48:878–81
    Abstract/FREE Full Text
  49. 49.↵


    1. Sarchielli  P, 
    2. Pelliccioli  GP, 
    3. Tarducci  R, 
    4. et al
    . Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001;43:189–97
    CrossRefPubMedWeb of Science
  50. 50.↵


    1. Mitsumoto  H, 
    2. Ulug  AM, 
    3. Pullman  SL, 
    4. et al
    . Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007;68:1402–10
    Abstract/FREE Full Text
  51. 51.↵


    1. Block  W, 
    2. Karitzky  J, 
    3. Traber  F, 
    4. et al
    . Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 1998;55:931–36
    CrossRefPubMedWeb of Science
  52. 52.↵


    1. Jones  AP, 
    2. Gunawardena  WJ, 
    3. Coutinho  CM, 
    4. et al
    . Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amyotrophic lateral sclerosis). J Neurol Sci 1995;129(suppl):85–89
    CrossRefPubMed
  53. 53.↵


    1. Pioro  EP, 
    2. Antel  JP, 
    3. Cashman  NR, 
    4. et al
    . Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44:1933–38
    Abstract/FREE Full Text
  54. 54.↵


    1. Rooney  WD, 
    2. Miller  RG, 
    3. Gelinas  D, 
    4. et al
    . Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998;50:1800–05
    Abstract/FREE Full Text
  55. 55.↵


    1. Pohl  C, 
    2. Block  W, 
    3. Karitzky  J, 
    4. et al
    . Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001;58:729–35
    CrossRefPubMedWeb of Science
  56. 56.↵


    1. Kalra  S, 
    2. Arnold  DL
    . Magnetic resonance spectroscopy for monitoring neuronal integrity in amyotrophic lateral sclerosis. Adv Exp Med Biol 2006;576:275–82, discussion 361–63
    CrossRefPubMed
  57. 57.↵


    1. Kalra  S, 
    2. Hanstock  CC, 
    3. Martin  WR, 
    4. et al
    . Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol 2006;63:1144–48
    CrossRefPubMed
  58. 58.↵


    1. Nelles  M, 
    2. Block  W, 
    3. Traber  F, 
    4. et al
    . Combined 3T diffusion tensor tractography and 1H-MR spectroscopy in motor neuron disease. AJNR Am J Neuroradiol 2008;29:1708–14
    Abstract/FREE Full Text
  59. 59.↵


    1. Wang  S, 
    2. Poptani  H, 
    3. Woo  JH, 
    4. et al
    . Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 2006;239:831–38
    CrossRefPubMedWeb of Science
  60. 60.↵


    1. Pyra  T, 
    2. Hui  B, 
    3. Hanstock  C, 
    4. et al
    . Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010;11:157–65
    CrossRefPubMed
  61. 61.↵


    1. Cwik  VA, 
    2. Hanstock  CC, 
    3. Allen  PS, 
    4. et al
    . Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50:72–77
    Abstract/FREE Full Text
  62. 62.↵


    1. Ellis  CM, 
    2. Simmons  A, 
    3. Andrews  C, 
    4. et al
    . A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998;51:1104–09
    Abstract/FREE Full Text
  63. 63.↵


    1. Abe  K, 
    2. Takanashi  M, 
    3. Watanabe  Y, 
    4. et al
    . Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology 2001;43:537–41
    CrossRefPubMedWeb of Science
  64. 64.↵


    1. Kaufmann  P, 
    2. Pullman  SL, 
    3. Shungu  DC, 
    4. et al
    . Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004;62:1753–57
    Abstract/FREE Full Text
  65. 65.↵


    1. Bowen  BC, 
    2. Pattany  PM, 
    3. Bradley  WG, 
    4. et al
    . MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000;21:647–58
    Abstract/FREE Full Text
  66. 66.↵


    1. Cosottini  M, 
    2. Giannelli  M, 
    3. Siciliano  G, 
    4. et al
    . Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005;237:258–64
    CrossRefPubMedWeb of Science
  67. 67.↵


    1. Ellis  CM, 
    2. Simmons  A, 
    3. Jones  DK, 
    4. et al
    . Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999;53:1051–58
    Abstract/FREE Full Text
  68. 68.↵


    1. Toosy  AT, 
    2. Werring  DJ, 
    3. Orrell  RW, 
    4. et al
    . Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:1250–57
    Abstract/FREE Full Text
  69. 69.↵


    1. Abe  O, 
    2. Yamada  H, 
    3. Masutani  Y, 
    4. et al
    . Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis. NMR Biomed 2004;17:411–16
    CrossRefPubMedWeb of Science
  70. 70.↵


    1. Iwata  NK, 
    2. Aoki  S, 
    3. Okabe  S, 
    4. et al
    . Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology 2008;70:528–32
    Abstract/FREE Full Text
  71. 71.↵


    1. Graham  JM, 
    2. Papadakis  N, 
    3. Evans  J, 
    4. et al
    . Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004;63:2111–19
    Abstract/FREE Full Text
  72. 72.↵


    1. Schimrigk  SK, 
    2. Bellenberg  B, 
    3. Schluter  M, 
    4. et al
    . Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model. AJNR Am J Neuroradiol 2007;28:724–30
    Abstract/FREE Full Text
  73. 73.↵


    1. Senda  J, 
    2. Ito  M, 
    3. Watanabe  H, 
    4. et al
    . Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: a study with tractography and diffusion-tensor imaging. Amyotroph Lateral Scler 2009;10:288–94
    CrossRefPubMedWeb of Science
  74. 74.↵


    1. Ciccarelli  O, 
    2. Behrens  TE, 
    3. Altmann  DR, 
    4. et al
    . Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. Brain 2006;129:1859–71
    Abstract/FREE Full Text
  75. 75.↵


    1. Sage  CA, 
    2. Peeters  RR, 
    3. Gorner  A, 
    4. et al
    . Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007;34:486–99
    CrossRefPubMedWeb of Science
  76. 76.↵


    1. Hughes  JT
    . Pathology of amyotrophic lateral sclerosis. Adv Neurol 1982;36:61–74
    PubMed
  77. 77.↵


    1. Lawyer  T  Jr., 
    2. Netsky  MG
    . Amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry 1953;69:171–92
    PubMedWeb of Science
  78. 78.↵


    1. da Rocha  AJ, 
    2. Oliveira  AS, 
    3. Fonseca  RB, 
    4. et al
    . Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence. AJNR Am J Neuroradiol 2004;25:1509–15
    Abstract/FREE Full Text
  79. 79.↵


    1. Tanabe  JL, 
    2. Vermathen  M, 
    3. Miller  R, 
    4. et al
    . Reduced MTR in the corticospinal tract and normal T2 in amyotrophic lateral sclerosis. Magn Reson Imaging 1998;16:1163–69
    CrossRefPubMedWeb of Science
  80. 80.↵


    1. Kato  Y, 
    2. Matsumura  K, 
    3. Kinosada  Y, 
    4. et al
    . Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. AJNR Am J Neuroradiol 1997;18:1541–47
    Abstract
  81. 81.↵


    1. Filippi  M, 
    2. Rocca  MA
    . Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics 2007;4:401–13
    PubMed
  82. 82.↵


    1. Konrad  C, 
    2. Henningsen  H, 
    3. Bremer  J, 
    4. et al
    . Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Exp Brain Res 2002;143:51–56
    CrossRefPubMedWeb of Science
  83. 83.↵


    1. Konrad  C, 
    2. Jansen  A, 
    3. Henningsen  H, 
    4. et al
    . Subcortical reorganization in amyotrophic lateral sclerosis. Exp Brain Res 2006;172:361–69
    CrossRefPubMedWeb of Science
  84. 84.↵


    1. Schoenfeld  MA, 
    2. Tempelmann  C, 
    3. Gaul  C, 
    4. et al
    . Functional motor compensation in amyotrophic lateral sclerosis. J Neurol 2005;252:944–52
    CrossRefPubMedWeb of Science
  85. 85.↵


    1. Stanton  BR, 
    2. Williams  VC, 
    3. Leigh  PN, 
    4. et al
    . Altered cortical activation during a motor task in ALS: evidence for involvement of central pathways. J Neurol 2007;254:1260–67
    CrossRefPubMedWeb of Science
  86. 86.↵


    1. Tessitore  A, 
    2. Esposito  F, 
    3. Monsurro  MR, 
    4. et al
    . Subcortical motor plasticity in patients with sporadic ALS: an fMRI study. Brain Res Bull 2006;69:489–94
    CrossRefPubMedWeb of Science
  87. 87.↵


    1. Neary  D, 
    2. Snowden  JS, 
    3. Gustafson  L, 
    4. et al
    . Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–54
    Abstract/FREE Full Text
  88. 88.↵


    1. Murphy  JM, 
    2. Henry  RG, 
    3. Langmore  S, 
    4. et al
    . Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007;64:530–34
    CrossRefPubMedWeb of Science
  89. 89.↵


    1. Avants  B, 
    2. Khan  A, 
    3. McCluskey  L, 
    4. et al
    . Longitudinal cortical atrophy in amyotrophic lateral sclerosis with frontotemporal dementia. Arch Neurol 2009;66:138–39
    CrossRefPubMed
  90. 90.↵


    1. Agosta  F, 
    2. Gorno-Tempini  ML, 
    3. Pagani  E, 
    4. et al
    . Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: a tensor based morphometry study. Amyotroph Lateral Scler 2009;10:168–74
    PubMedWeb of Science
  91. 91.↵


    1. Ciccarelli  O, 
    2. Behrens  TE, 
    3. Johansen-Berg  H, 
    4. et al
    . Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp 2009;30:615–24
    CrossRefPubMedWeb of Science
  92. 92.↵


    1. Sach  M, 
    2. Winkler  G, 
    3. Glauche  V, 
    4. et al
    . Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004;127:340–50
    Abstract/FREE Full Text
  93. 93.↵


    1. Sage  CA, 
    2. Van Hecke  W, 
    3. Peeters  R, 
    4. et al
    . Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp 2009;30:3657–75
    CrossRefPubMedWeb of Science
  94. 94.↵


    1. Abrahams  S, 
    2. Goldstein  LH, 
    3. Simmons  A, 
    4. et al
    . Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 2004;127:1507–17
    Abstract/FREE Full Text
  95. 95.↵


    1. Lule  D, 
    2. Diekmann  V, 
    3. Anders  S, 
    4. et al
    . Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). J Neurol 2007;254:519–27
    CrossRefPubMedWeb of Science
  96. 96.↵


    1. Wijesekera  LC, 
    2. Leigh  PN
    . Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009;4:3
    CrossRefPubMed
  97. 97.↵


    1. Suhy  J, 
    2. Miller  RG, 
    3. Rule  R, 
    4. et al
    . Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MR spectroscopy. Neurology 2002;58:773–79
    Abstract/FREE Full Text
  98. 98.↵


    1. Unrath  A, 
    2. Ludolph  AC, 
    3. Kassubek  J
    . Brain metabolites in definite amyotrophic lateral sclerosis: a longitudinal proton magnetic resonance spectroscopy study. J Neurol 2007;254:1099–106
    CrossRefPubMed
  99. 99.↵


    1. Rule  RR, 
    2. Suhy  J, 
    3. Schuff  N, 
    4. et al
    . Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:141–49
    PubMed
  100. 100.↵


    1. Blain  CR, 
    2. Williams  VC, 
    3. Johnston  C, 
    4. et al
    . A longitudinal study of diffusion tensor MRI in ALS. Amyotroph Lateral Scler 2007;8:348–55
    CrossRefPubMedWeb of Science
  101. 101.↵


    1. Kalra  S, 
    2. Cashman  NR, 
    3. Genge  A, 
    4. et al
    . Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757–61
    PubMedWeb of Science
  102. 102.↵


    1. Kalra  S, 
    2. Tai  P, 
    3. Genge  A, 
    4. et al
    . Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J Neurol 2006;253:1060–63
    CrossRefPubMedWeb of Science
  103. 103.↵


    1. Kalra  S, 
    2. Cashman  NR, 
    3. Caramanos  Z, 
    4. et al
    . Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. AJNR Am J Neuroradiol 2003;24:476–80
    Abstract/FREE Full Text
  104. 104.↵


    1. Kalra  S, 
    2. Genge  A, 
    3. Arnold  DL
    . A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:22–26
    CrossRefPubMedWeb of Science
  105. 105.↵


    1. Schenck  JF, 
    2. Zimmerman  EA
    . High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004;17:433–45
    CrossRefPubMedWeb of Science
  106. 106.↵


    1. Lule  D, 
    2. Diekmann  V, 
    3. Kassubek  J, 
    4. et al
    . Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function. Neurorehabil Neural Repair 2007;21:518–26
    Abstract/FREE Full Text
  107. 107.↵


    1. Mohammadi  B, 
    2. Kollewe  K, 
    3. Samii  A, 
    4. et al
    . Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol 2009;217:147–53
    CrossRefPubMedWeb of Science
  108. 108.↵


    1. Corrado  L, 
    2. Del Bo  R, 
    3. Castellotti  B, 
    4. et al
    . Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet 2010;47:190–94
    Abstract/FREE Full Text
  109. 109.↵


    1. Belzil  VV, 
    2. Valdmanis  PN, 
    3. Dion  PA, 
    4. et al
    . Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology 2009;73:1176–79. Epub 2009 Sep 9
    Abstract/FREE Full Text
  110. 110.↵


    1. Kirby  J, 
    2. Goodall  EF, 
    3. Smith  W, 
    4. et al
    . Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis. Neurogenetics 2010;11:217–25
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis
  
    	
F. Agosta, A. Chiò, M. Cosottini, N. De Stefano, A. Falini, M. Mascalchi, M.A. Rocca, V. Silani, G. Tedeschi, M. Filippi

  
    	
 American Journal of Neuroradiology Nov 2010, 31 (10) 1769-1777; DOI: 10.3174/ajnr.A2043 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement